A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.


Updates from The Motley Fool

Latest updates on BIOLASE from Fool.com.
The Stocks Wall Street Loves

Analysts are unanimously bullish, but do you agree with these Wall Street darlings?

BioLase's Dull Quarter

Dental laser maker makes good on its promise of a disappointing quarter, but future may be bright.

BioLase Darkens Smiles

The dental laser maker warns that quarterly revenues will be dramatically lower.

BioLase's Reason to Smile

Dental laser maker narrows loss and inks distribution deal to boost sales.



Stock Performance

View Interactive BIOL Charts
Sponsored by

Key Data Points

Primary metrics and data points about BIOLASE.
Current Price: $1.53
Prev Close: $1.51
Open: $1.51
Bid: $1.52
Ask: $1.53
Day's Range: $1.50 - $1.53
52wk Range: $0.80 - $1.98
Volume: 74,390
Avg Vol 261,306
Market Cap: $89M
P/E (ttm): -6.29
EPS (ttm): ($0.24)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BIOLASE.
CAPS Rating 1 out of 5
 
74 Outperform
26 Underperform
CAPS All Stars
 
6 Outperform
8 Underperform

How do you think BIOLASE will perform against the market?



You pick for BIOLASE is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Harold Flynn, CEO

75% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BIOLASE.

A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT